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Abstract
Background/Aim: Recent interest in the liver stem cell field has led to the identification and
characterization of several hepatic progenitor cell populations from fetal and adult tissues. We
isolated a hepatic progenitor cell from naïve adult liver and the current studies focus on differentiation
and growth.
Results: A Sca-1+ hepatic progenitor cell was identified within the liver parenchyma. This cell
expresses numerous liver related genes and transcription found in the developing and/or adult liver.
It is located in the peri-portal region and expresses markers associated with undifferentiated hepatic
cell populations, mature hepatocytes and biliary cells which distinguish it from the Sca-1-fraction.
Conclusion: This hepatic progenitor cell from uninjured liver has features of both hepatocytic and
biliary populations and demonstrates proliferative potential. Further studies will focus on sca-HPC
subsets and conditions that regulate differentiation towards hepatic or biliary lineages.
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Introduction
The breadth of liver-related stem cell research has been focused on fetal-derived hepatic stem
cell or oval cell populations [1-7]. Alternative approaches include isolating proliferative
populations from the liver using hepatic injury models that inhibit mature hepatocyte
replication [8,9]. In addition, bipotent progenitor cells capable of multiple rounds of cell
division have been identified without a preceding injury to the liver [10-12]. The population
of “small hepatocytes” from adult rat liver described by Mitaka et al. is mononuclear with a
less differentiated morphologic appearance [10]. Fujikawa et al isolated α-fetoprotein (AFP)
positive cells from adult liver with immature endodermal characteristics that were capable of
differentiating into both hepatic and biliary cell lineages [13]. More recently Fougere-
Deschatrette et al isolated bipotential clonal cell lines from adult murine liver. They
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demonstrated the persistence of gene transcription of several liver related factors during
extended passage along with overlap of select oval cell and biliary markers [12]. In contrast a
select human hepatic stem cell population expressed numerous hepatic markers but no
hematopoietic or biliary markers [14]. The summary of these works has generated multiple
descriptions of potential hepatic progenitor cells with the possibility that overlap exists among
them.
Several stem cell associated markers have generated interest in non-hematopoietic stem cell
research. The murine stem cell antigen, SCA-1, (Ly6A/E) is a molecule that belongs to the
Ly-6 multigene family [15,16] and is expressed on hematopoietic stem cells (HSC) [15].
Petersen et al demonstrated Sca-1 expression on murine oval cells using an experimental injury
model to induce oval cell proliferation [17]. Nierhoff et al demonstrated that a purified fetal
liver epithelial cell population expressed Sca-1 and could give rise to functional mature
hepatocytes [18]. Several groups have shown that liver-derived endothelial cells, and their
precursors also express Sca-1 on the cell surface [15,19].
We initially identified a tissue-derived hepatic progenitor cell population from adult liver
contained within a mixed cell fraction of non-parenchymal cells [11]. The aim of this study
was to enrich the hepatic progenitor cell compartment of the adult liver by identifying a marker
that would aid in the purification of the hepatic progenitor cell population.
Materials and Methods
Reagents in these experiments were from Sigma, St. Louis, MO unless otherwise stated.
Mice
C57BL/6 mice (6-8 weeks old) were purchased from the Jackson Laboratory (Bar Harbor, ME)
and used for all of the experiments. All care and use of animals was approved by the Institutional
Animal Care and Use Committee at the University of North Carolina at Chapel Hill in
accordance with the principles and procedures outlined in the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Hepatic Progenitor Cell Isolation
Hepatic progenitor cell containing fraction was isolated as previously described [11].
Enrichment of Sca-1+-Hepatic Progenitor Cells
Sorting of liver cells was performed using a Sca-1 antibody conjugated to mini-magnetic beads
(Miltenyi Biotec, Inc.; Auburn, CA, http://www.miltenyibiotec.com) according to the
manufacturer's instructions. Sca1+ cells were eluted with a purity of >99% by flow cytometry
and >80% viability.
In-vitro cell culture
The Sca-1+-HPCs (sca-HPCs) were cultured in Dulbecco's Modified Eagle Medium (DMEM)
(Gibco; Carlsbad, California ) plus 10% fetal bovine serum (FBS), 20mM hepes, 10mM
nicotinamide, 1 mM ascorbic acid 2-phosphate, 1 μM dexamethasone, 0.5 mg/L ITS (insulin-
transferrin-selenium) solution, 30 mg/L proline, 100 mg/L antibiotic solution (Gibco), and 10
ng/mL epidermal growth factor (EGF) supplemented with conditioned media from previously
unfractionated non-parenchymal cell population. The sca-HPCs were plated at a density of
8×104 cells/cm2. Tissue culture dishes were cultured in a 5% CO2 incubator at 37°C and the
media was changed at regular time intervals.
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Liver tissue was formaldehyde fixed and paraffin embedded. Five μm thick sections were cut
and subjected to further immunohistochemical examination.
Histology and Immunohistochemical Characterization
Immunohistochemistry was performed by an indirect immunoperoxidase procedure for
localization of select proteins. Primary antibody was against Sca-1 (BD Pharmingen™; San
Jose, CA). The secondary antibody was from Vector Laboratories (Burlingame, CA) and the
signal was detected using the ABC Elite and DAB kits (Vector Laboratories). All stained slides
were viewed on the Nikon Microphot-FXA microscope equipped with an Optronics DEI 750
3-chip CCD camera and a Q Imaging Micropublisher CCD camera for digital image
acquisition. Images were captured on an Apple Power Macintosh G3 computer utilizing Q
Imaging software.
Fluroescent immunophenotyping and flow cytometry
Cells were stained for immunofluorescence using antibodies directly labeled with the relevant
fluoroprobe. Unstained cells, cells stained with an irrelevant antibody and the same fluoroprobe
or with the same antibody but no fluoroprobe were used as negative and isotype controls. Cells
were suspended in room temperature HBSS containing 2% FBS and 2 mM HEPES buffer (SP
buffer) at 5 × 106 cells per ml. Antibodies were primary conjugates against CD117, CD34 and
CD45 (BD Biosciences; San Jose, CA). Cells were incubated for 90 minutes, centrifuged and
resuspended in cold buffer at 5 × 106 per ml.
Isolation of Sca-1 negative cell fraction
The Sca-1 negative cell fraction was separated and confirmed using the Modular Flow (Mo
Flo) cytometer from Cytomation Inc (Fort Collins, CO).
Reverse Transcription-Polymerase Chain Reaction
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Inc.; Valencia, CA) and quality
confirmed on an Agilent 2100 BioAnalyzer (Agilent Technologies Inc.; Palo Alto, CA). Two
micrograms of total RNA, were reverse-transcribed using the RETROscript® Reverse
Transcription Kit (Ambion; Austin, TX). Polymerase chain reaction (PCR) was performed as
follows: 94°C, 30 seconds; 55-60°C, 1 minute; and 72°C, 1 minute for 40 cycles. Primer
sequences for the genes are in the supplemental data.
Western Blot Analysis
Cells were lysed in buffer containing 50mM Tris, 150mM NaCl, 1% Nonidet P40 (Roche;
Indianapolis, IN) , 0.5% deoxycholate, 1mL protease inhibitor cocktail for every 100mL
(5μg/mL aprotinin, leupeptin, pepstatin, and soybean trypsin inhibitor), and 1mL phosphatase
inhibitor for every 100mL. Lysates were clarified by centrifugation at 14,000g × 2 min and
stored at −20°C. Protein concentrations were determined by Bio-Rad protein assay. Total
cellular proteins (50 μg/lane) were dissolved by SDS-PAGE, transferred to nitrocellulose
membrane incubated with blocking buffer (5% nonfat dry milk in 1x Tris Buffered Saline with
0.05% Tween 20, pH 7.5), and probed with primary antibodies. After incubation with
secondary antibodies, peroxidase activity was detected by enhanced chemiluminescence.
Densitometric signals from Western blots were analyzed with NIH-ImageJ software
(http://rsb.info.nih.gov/ij/) [20]. Protein levels were calculated in arbitrary units (AU)
normalized with β-actin protein levels.
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The 3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyl tetrazolium bromide (MTT) assay quantifies
cell number (Sigma; CGD-1) based on the MTT-Formazan assay [21,22]. Cells were cultured
on 96-well flat bottom plates in 150 μL of media. MTT equal to 10% culture volume in RPMI
1640 medium and the plates were kept at 37°C for 4 hrs in a humidified incubator. Media was
removed and the cells were incubated with 150μL MTT solvent (0.1 N HCl in anhydrous
isopropanol) until the purple formazan crystals were dissolved. The absorbance was read at
570 nm and 690nm using a microplate reader. The cell number was calculated from a standard
absorbance curve [23].
RESULTS
Enrichment and Expansion of the Sca-1+ HPC (sca-HPC)
Having isolated a mixed cell population containing hepatic progenitor cells (HPC) from naïve
adult murine liver tissue [11], our focus has been directed towards purification of the HPC
from the non-parenchymal cell fraction. With our mechanical separation technique, there is an
average of 29.3 ± 6.2 × 106 cells (HPC + NPC) in the supernatant fraction/ liver. This NPC
fraction contains a heterogeneous mix of stellate cells, Kupffer cells and biliary cells in addition
to the HPC population [11]. Other investigators demonstrated Sca-1 expression on fetal liver
stem cell or select oval cell populations generated in specific injury models [17,18,24]. We
analyzed the NPC fraction by flow cytometric analysis and found that 15.4% ± 3.7% of the
cells in this fraction express Sca-1. [Figure 1]
To separate the HPCs from the NPC we incorporated a magnetic activated cell sorting
(MACS®; Miltenyi, Biotec, Inc.) procedure. The MACS® process purifies our cell population
giving us >98% Sca-1+ cells from the total cell fraction with >80% viability. (Data not shown)
Sca-1+ HPC (sca-HPC) obtained with this protocol are used for all subsequent experiments.
Analysis for expression of additional stem cell related markers was performed on the
immediately isolated sca-HPC population. The sca-HPC demonstrates co-expression of CD45,
CD117 and CD34 (46.8±8.5%, 26.3±6.0% and 2.2±0.4% respectively) on subsets of this
enriched population. [Figure 1]
The subsequent experiments were directed at expanding the sca-HPC population. In our initial
experiments the purified sca-HPC population was cultured using routine culture conditions
[11] but the cells did not proliferate or form colonies. We hypothesized that the missing NPC
populations were requisite to support proliferation of the sca-HPC either via direct cell-cell
interactions or cytokine production. We generated conditioned media by culturing the total
NPC cell fraction (HPC + NPC) as had been used in our earlier work and media was collected
from these dishes at 48 hour intervals. Fresh culture medium was then supplemented in a 3:1
ratio with the conditioned media to generate a 25% conditioned media for use in our
experiments. Under these conditions there is reproducible sca-HPC colony formation. A
phenotypic difference is demonstrated between the sca-HPC and the remaining Sca− (or NPC)
fraction.[Data not shown]
Cellular Localization within Liver Parenchyma
After selecting Sca-1 as a marker we wanted to identify where these cells arise within the liver.
Murine liver was analyzed from two age groups; 15 day old mice and 6 week old mice to
characterize the in situ location of these cells. In both age groups, cells are identified in the
periportal region [Figure 2].
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Gene Expression of sca-HPCs
The next experiments characterize the sca-HPC's expression of genes associated with
differentiated hepatocytes, biliary cells and transcription factors associated with the developing
liver. Immediately after isolation the sca-HPC expresses numerous liver transcription factors.
[Figure 3] The sca-HPC expresses a number of apolipoproteins along with genes associated
with mature hepatocytes (i.e., tyrosine amino transferase [TAT], retinol binding protein,
transferrin, albumin and tryptophan dioxygenase [TO]). The sca-HPC also expresses AFP (a
marker of immature hepatic cells) and CK-19 (a marker of biliary epithelial cells). [Figure 3]
For comparison, we analyzed the Sca-1 negative fraction of cells (the remaining NPC
population). [Supplemental Material; Table 1]
Differentiation and Bipotency of sca-HPCs
Sca-HPCs established in culture under experimental conditions are analyzed for their ability
to differentiate into mature cell types. Using Western blot analysis the sca-HPCs are analyzed
for albumin and AFP (hepatocytic markers) and CK-19 (a biliary marker) to define the cell's
bipotent potential. Immediately after isolation the sca-HPCs express CK-19, AFP, and albumin
which persists for two weeks of culture under our established growth conditions. [Figure 4 and
Supplemental Data]
Numerous culture conditions have been published with respect to supporting differentiation of
liver cells towards biliary or hepatic phenotypes [25]. Based on this work the sca-HPCs are
cultured under two distinct conditions to support differentiation. They are: 50ng/mL EGF +
2% DMSO and 40ng/mL HGF + dexamethasone without EGF in the media. For comparison
sca-HPC in routine growth conditions plus 25% conditioned media were used as controls. In
the control the cells demonstrate a decrease in albumin and AFP with a concomitant increase
in CK-19 expression. Under both experimental conditions the cells demonstrate a decrease in
expression of albumin, AFP and CK-19 compared with control cells.
Sca-HPC Viability and Proliferation
The formation of sca-HPC colonies begins at day 4-5 of primary cell culture. What remains
unclear is whether this is an intrinsic delay in the pathways associated with cellular
proliferation. We analyzed sca-HPC viability and proliferation in primary cell culture using
thymidine incorporation during the first 4 days (or 96 hours) of primary culture. This time
frame represents the period prior to visualization of colony formation. We also employed an
MTT assay to evaluate viable sca-HPCs. In the [3H] thymidine assay there is a basal level of
DNA synthesis during the first 48 hours of culture followed by a spike in activity during the
subsequent 48 hour period. [Supplemental data] Using the MTT assay we observe a stable
number of sca-HPCs through the first 4 days of culture followed by a >3 fold increase in sca-
HPCs after day 4. [Supplemental data]
DISCUSSION
We previously isolated a heterogeneous cell population from naïve adult liver that contained
a presumed hepatic progenitor cell population [11]. Unfortunately challenges in our initial work
involved the heterogeneity of this cellular fraction as this population included the non-
parenchymal cells (e.g. stellate cells, etc.). In these experiments we focused on enrichment and
subsequent analysis of the sca-HPC separately from other NPC. Our strategy involved
identifying one or more unique cell surface markers. Figure 1 demonstrates that a defined subset
of the initial NPC express Sca-1 on their surface. Therefore using an antibody selection method
we isolated these cells and established culture conditions that support their proliferation and
ability to form colonies.
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In-depth analysis of these cells demonstrates that a subset of the sca-HPC is positive for select
stem-cell related markers (e.g. CD34, CD45 and CD 117) each of which has been shown to be
important in various oval cell studies [6,26-28]. [Figure 1] These findings are very interesting
as they suggest that within the sca-HPC population there is diversity with multiple
subpopulations. This finding could reflect variability in the state of cell differentiation and is
important as several investigators have previously demonstrated heterogeneity of progenitor/
stem cell populations with varying abilities to differentiate and/or proliferate [29,30].
Investigating the in situ location of this population is critical to understanding the cell's origin
and association with other cellular populations of the liver. Interestingly in the young mice the
cells are primarily located in the periportal region [data not shown] while in the adult mice
they are located in closer proximity to the bile ducts. [Figure 2] They also have the morphologic
appearance of small periportal hepatocytes [31]. Sca+ cells were also demonstrated along the
endothelium of the portal vein [29]. [Data not shown]
A series of experiments investigated transcription factor and liver related gene expression in
the sca-HPC population suggest that the sca-HPC is similar to fetal liver cells[8]. [Figure 3
and Table 1] Interestingly, the Sca-negative fraction demonstrates a number of hepatocyte
function markers which we believe this is secondary to cellular contamination with a number
of mature hepatocytes. Using a culture system to distinguish the sca-HPC and Sca-negative
cells we found that the latter population is compromised of a population of cuboidal cells that
express very few of the developmental markers found in the Sca-HPC nor do they express AFP
or CK-19. [Table 1]
We evaluated the sca-HPC for expression of hepatic and biliary markers during proliferation
and found a decrease in albumin and AFP expression to levels that were approximately 50%
of their expression immediately after isolation. Interestingly there was a more than 2-fold
increase in the expression of CK-19 during this same time period. These findings are intriguing
and we postulate that the sca-HPCs may be dedifferentiating in culture; a similar phenomenon
had been demonstrated with mature hepatocytes in culture [25] and with other HPC populations
[12]. Using a culture system that supports differentiation of hepatocytic cells along a biliary
lineage the sca-HPCs did not differentiate towards a specific phenotype and while there was a
loss of AFP expression with persistent expression of CK-19 there was also a decrease in
albumin expression. [Figure 4]
In summary, these experiments are a step towards understanding the biology of hepatic
progenitor cells from naïve adult liver. Our characterization is important as there are some
similarities with previously described populations from fetal and adult tissues. In addition, the
cell differentiation results are critical as we expand our knowledge of these unique populations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Representative flow cytometric analysis of freshly isolated hepatic progenitor cell (HPC)-
containing cell fraction from liver and stained for Sca-1 antibody. The highlighted box
(Sca-1+ HPC) represents 15.4 + 3.7 % of the total cell fraction (after depleting mature
hepatocytes). The sca-HPC cell population was subsequently analyzed for expression of CD34,
CD 117 or CD45 immediately after isolation. Analysis represents the average from three
individual isolations.
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Sca-1 staining was performed on liver at varying stages of development. Normal 6 week old
liver; Sca+ cells are located in the portal region (black arrows) primarily around the bile ducts.
[Original objective lens magnification: 20x].
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Reverse transcription-polymerase chain reaction (RT-PCR) analysis of select transcription
factors and liver-related genes from Sca-HPC.
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Western blot analysis of sca-HPC. Sca-HPC were isolated and analyzed for expression of
CK-19, AFP and albumin at day 14 in routine growth conditions; 50ng/mL EGF + 2% DMSO
or 40ng/mL HGF + dexamethasone. Comparisons were made with primarily isolated Sca-HPC.
Densitometric signals from Western blots were analyzed with NIH-ImageJ software
(http://rsb.info.nih.gov/ij/). Protein levels were calculated in arbitrary units (AU) normalized
to sample β-Actin protein levels.
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